Advanced Search

Pulmonary Vascular Diseases Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of Nick Morrell

    Nick Morrell

    Department of Medicine, University of Cambridge, Cambridge, UK

  • Photo of Lewis Rubin

    Lewis Rubin

    Division of Pulmonary and Critical Care Medicine, UCSD Medical Center, La Jolla, CA, USA

Section Topics

  • » Acute thrombo-embolic disease
  • » Arteriovenous malformations
  • » Hereditary hemorrhagic telengiectasia
  • » High-altitude pulmonary vascular diseases
  • » Pulmonary arterial hypertension: idiopathic & familial
  • » Pulmonary arterial hypertension: pulmonary venous hypertension
  • » Pulmonary arterial hypertension: related to collagen vascular disease
  • » Pulmonary arterial hypertension: related to portal hypertension, HIV, drugs & toxins, persistent pulmonary hypertension of the newborn
  • » Pulmonary hypertension: associated with respiratory system disease
  • » Pulmonary hypertension: chronic thrombo-embolic
  • » Pulmonary hypertension: miscellaneous causes

LATEST EVALUATION

This paper underscores the major importance of an intact signalling through bone morphogenetic proteins (BMPs) and their receptor (BMPR2) for prevention of pulmonary hypertension.

Lars Huber and Matthias Brock, University Hospital Zurich, Switzerland. F1000 Respiratory Disorders

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

8
Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.

Cahill E, Costello CM, Rowan SC, Harkin S, ..., Taylor C, Morrell NW, Martin F, McLoughlin P. Circulation. 2012 Jan 13

1 Evaluation, most recent by

Lars Huber and Matthias Brock, University Hospital Zurich, Switzerland. F1000 Respiratory Disorders

  • New Finding

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000